IP Verse

Elan Pharmaceuticals competitive analysis

Latest publications and patents of Elan Pharmaceuticals New

Explore the latest publications and patents granted to Elan Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 25, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Elan Pharmaceuticals

EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic AgentPatent Maintained As Amended
EP1793855
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic DiseasePatent Maintained As Amended
EP1991267
Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabRevoked

Latest patents of Elan Pharmaceuticals opposed by its competitors

Explore Elan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP1793855
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP1991267
Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1

Latest PTAB cases involving Elan Pharmaceuticals

Discover the latest PTAB cases involving Elan Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elan Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ELAN PHARMACEUTICALS - 3 - - Non-Active
MATHYS & SQUIRE49 - - - Highly Aggressive
PHARMACEUTICAL WORKS POLPHARMA3 - - - Highly Aggressive